Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report)’s share price traded down 9.9% during trading on Monday . The stock traded as low as $1.18 and last traded at $1.18. 191 shares changed hands during trading, a decline of 68% from the average session volume of 599 shares. The stock had previously closed at $1.31.
Idorsia Stock Performance
The firm has a 50 day moving average of $0.99 and a 200 day moving average of $1.36.
About Idorsia
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Featured Articles
- Five stocks we like better than Idorsia
- How to buy stock: A step-by-step guide for beginners
- Energy Transfer: Powering Data With Dividends and Diversification
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Qualcomm Stock Is Coiling for a Breakout
- Pros And Cons Of Monthly Dividend Stocks
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
